BioCentury
ARTICLE | Company News

Avrobio acquires cystinosis program from GenStem

December 1, 2017 9:41 PM UTC

In October, GenStem Therapeutics Inc. (San Diego, Calif.) granted Avrobio Inc. (Cambridge, Mass.) exclusive, worldwide rights to cystinosis gene therapy AVR-RD-04. Financial details are not disclosed...